Live from Stage 4: MBC News for Us, by Us
Could a cure for breast cancer be closer than you think? Welcome to "Live from Stage 4" — a bold, hopeful podcast where people living with metastatic breast cancer, clinicians, and researchers take center stage. We share real stories, decode the science, and spotlight the ideas and breakthroughs that matter — for patients, caregivers, and anyone who believes progress is possible. This podcast is for us, by us, and all about us.
Live from Stage 4: MBC News for Us, by Us
Latest Episodes
Developing Story: The Trial That Dares to Say Cure with Dr. Lior Braunstein
We've always been told that metastatic breast cancer can't be cured, only managed. But what if that's no longer the whole story?In this episode of Live from Stage 4, hosts Victoria Goldberg and Dr. Ellen Landsberger sit down wit...
Developing Story: CureWise Goes Live - The AI Platform Built by Cancer Patients, for Cancer Patients
Last time, we had a front row seat to a vision. This time, that vision has a launch date.On June 20th, CureWise officially launched, and for every cancer patient who walks into an oncologist's office with ten minutes and no idea what to ...
Developing Story: Beyond Camizestrant — The Evolving Landscape of ER+/HER2- MBC with Dr. Sarah Premji
The field of hormone receptor-positive, HER2-negative metastatic breast cancer is moving faster than ever, and in this episode, we go beyond SERENA-6 to map the full picture of what's changing.Joining hosts Victoria Goldberg and Abigail ...
Symptoms Spotlight: Neutropenia with Abigail Johnston and Melanie Sisk
In this episode of the Symptom Spotlight Series, hosts Abigail Johnston and Melanie Sisk are joined by Dr. Jill Tirabassi, this podcast's team member, to break down neutropenia. It is one of the most common and important side effects of cancer ...
Developing Story: The Camizestrant Vote, Doctors Weigh In with Dr. Sarah Sammons & Dr. Neil Vasan
Two weeks ago, we broke down the ODAC vote on camizestrant and SERENA-6 with seven patient advocates. This week, we go deeper — bringing in the clinical and regulatory perspectives from two of the most qualified voices in the field.We're...
